Healthcare - Biotechnology - NASDAQ - US
$ 2.71
-12.3 %
$ 8.14 M
Market Cap
-0.23
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
38.83%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Moleculin Biotech, Inc.
MBRX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart MBRX
EBIT FORECAST
EBIT Forecast Chart MBRX
NET INCOME FORECAST
Net Income Chart MBRX